Real-time Estimate
Other stock markets
|
|
5-day change | 1st Jan Change | |
37.04 USD | +2.08% | +3.89% | +59.59% |
Nov. 21 | Morgan Stanley Raises Price Target on Vistra to $41 From $40, Maintains Overweight Rating | MT |
Nov. 15 | The latest transactions by star fund managers | ![]() |
Valuation
Fiscal Period : December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 11 432 | 11 205 | 9 616 | 10 989 | 9 233 | 12 972 | - | - |
Enterprise Value (EV) 1 | 22 200 | 21 634 | 18 840 | 20 395 | 21 824 | 25 484 | 24 379 | 24 013 |
P/E ratio | -208x | 12,4x | 15,1x | -8,46x | -7,12x | 9,11x | 9,96x | 9,92x |
Yield | - | 2,17% | 2,75% | 2,64% | 3,10% | 2,22% | 2,47% | 2,72% |
Capitalization / Revenue | 1,25x | 0,95x | 0,84x | 0,91x | 0,67x | 0,79x | 0,77x | 0,78x |
EV / Revenue | 2,43x | 1,83x | 1,65x | 1,69x | 1,59x | 1,56x | 1,44x | 1,45x |
EV / EBITDA | 7,90x | 6,51x | 5,11x | 10,7x | 7,29x | 6,42x | 5,58x | 5,62x |
EV / FCF | 20,7x | 9,76x | 7,34x | -16,5x | -26,7x | 9,54x | 8,97x | 8,62x |
FCF Yield | 4,84% | 10,2% | 13,6% | -6,07% | -3,74% | 10,5% | 11,1% | 11,6% |
Price to Book | 1,44x | 1,41x | 1,15x | 1,29x | 1,84x | 4,13x | 3,48x | 2,89x |
Nbr of stocks (in thousands) | 499 446 | 487 394 | 489 134 | 482 628 | 397 954 | 357 552 | - | - |
Reference price 2 | 22,9 | 23,0 | 19,7 | 22,8 | 23,2 | 36,3 | 36,3 | 36,3 |
Announcement Date | 02/28/19 | 02/28/20 | 02/26/21 | 02/25/22 | 03/01/23 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
Fiscal Period : December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 9 144 | 11 809 | 11 443 | 12 077 | 13 728 | 16 368 | 16 891 | 16 528 |
EBITDA 1 | 2 809 | 3 325 | 3 685 | 1 908 | 2 994 | 3 970 | 4 370 | 4 273 |
EBIT 1 | 1 415 | 1 449 | 1 637 | -1 515 | -1 103 | 2 536 | 2 570 | 2 426 |
Operating Margin | 15,5% | 12,3% | 14,3% | -12,5% | -8,03% | 15,5% | 15,2% | 14,7% |
Earnings before Tax (EBT) 1 | -101 | 1 216 | 890 | -1 722 | -1 560 | 1 468 | 1 818 | 1 929 |
Net income 1 | -54,0 | 928 | 636 | -1 274 | -1 377 | 1 598 | 1 320 | 1 229 |
Net margin | -0,59% | 7,86% | 5,56% | -10,5% | -10,0% | 9,76% | 7,81% | 7,43% |
EPS 2 | -0,11 | 1,86 | 1,30 | -2,69 | -3,26 | 3,98 | 3,64 | 3,66 |
Free Cash Flow 1 | 1 075 | 2 216 | 2 567 | -1 239 | -816 | 2 671 | 2 717 | 2 786 |
FCF margin | 11,8% | 18,8% | 22,4% | -10,3% | -5,94% | 16,3% | 16,1% | 16,9% |
FCF Conversion (EBITDA) | 38,3% | 66,6% | 69,7% | - | - | 67,3% | 62,2% | 65,2% |
FCF Conversion (Net income) | - | 239% | 404% | - | - | 167% | 206% | 227% |
Dividend per Share 2 | - | 0,50 | 0,54 | 0,60 | 0,72 | 0,81 | 0,90 | 0,99 |
Announcement Date | 02/28/19 | 02/28/20 | 02/26/21 | 02/25/22 | 03/01/23 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period : December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 2 565 | 2 991 | 3 314 | 3 125 | 1 588 | 5 146 | 3 869 | 4 425 | 3 189 | 4 086 | 2 947 |
EBITDA 1 | 811 | 1 173 | 1 164 | 541 | 737 | 981 | 736 | 513 | 1 067 | 1 589 | 996 |
EBIT 1 | 62,0 | 119 | 886 | 169 | -1 683 | 894 | -24,0 | 109 | - | 834 | 150 |
Operating Margin | 2,42% | 3,98% | 26,7% | 5,41% | -106% | 17,4% | -0,62% | 2,46% | - | 20,4% | 5,10% |
Earnings before Tax (EBT) 1 | -80,0 | 41,0 | 841 | - | -1 764 | 914 | -336 | 876 | 599 | 671 | -80,1 |
Net income 1 | 36,0 | 7,00 | 726 | - | -1 365 | 668 | -284 | 661 | 439 | 465 | -488 |
Net margin | 1,40% | 0,23% | 21,9% | - | -86,0% | 13,0% | -7,34% | 14,9% | 13,8% | 11,4% | -16,5% |
EPS 2 | 0,07 | 0,01 | 1,45 | -0,72 | -3,27 | 1,51 | -0,73 | 1,71 | 1,17 | 1,25 | -0,52 |
Dividend per Share 2 | 0,15 | 0,15 | 0,15 | 0,17 | 0,18 | 0,18 | 0,19 | 0,17 | 0,20 | 0,21 | 0,18 |
Announcement Date | 08/05/21 | 11/05/21 | 02/25/22 | 05/06/22 | 08/05/22 | 11/04/22 | 03/01/23 | 05/09/23 | 08/09/23 | 11/07/23 | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
Fiscal Period : December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 10 768 | 10 429 | 9 224 | 9 406 | 12 591 | 12 512 | 11 407 | 11 041 |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 3,83x | 3,14x | 2,50x | 4,93x | 4,21x | 3,15x | 2,61x | 2,58x |
Free Cash Flow 1 | 1 075 | 2 216 | 2 567 | -1 239 | -816 | 2 671 | 2 717 | 2 786 |
ROE (net income / shareholders' equity) | -0,76% | 11,7% | 10,3% | -15,3% | -20,9% | 39,9% | 35,8% | 30,8% |
Shareholders' equity 1 | 7 102 | 7 911 | 6 187 | 8 331 | 6 597 | 4 003 | 3 682 | 3 996 |
ROA (Net income/ Total Assets) | -0,27% | 3,53% | 3,24% | -4,64% | -4,41% | 6,70% | 3,50% | 3,40% |
Assets 1 | 20 308 | 26 320 | 19 635 | 27 446 | 31 235 | 23 853 | 37 712 | 36 140 |
Book Value Per Share 2 | 15,9 | 16,3 | 17,1 | 17,7 | 12,6 | 8,78 | 10,4 | 12,6 |
Cash Flow per Share 2 | 2,91 | 5,47 | 6,80 | -0,43 | 1,15 | 14,7 | 13,0 | - |
Capex 1 | 396 | 520 | 770 | 1 033 | 1 301 | 1 457 | 1 354 | 1 373 |
Capex / Sales | 4,33% | 4,40% | 6,73% | 8,55% | 9,48% | 8,90% | 8,02% | 8,31% |
Announcement Date | 02/28/19 | 02/28/20 | 02/26/21 | 02/25/22 | 03/01/23 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating :
Investor Rating :
ESG Refinitiv :
B+
Sell
Buy

Mean consensus
BUY
Number of Analysts
10
Last Close Price
36.28USD
Average target price
39.5USD
Spread / Average Target
+8.88%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.59% | 12 972 M $ | |
-29.50% | 121 B $ | |
+0.04% | 78 001 M $ | |
+5.35% | 77 423 M $ | |
+29.92% | 71 797 M $ | |
-9.81% | 71 399 M $ | |
-15.30% | 42 338 M $ | |
-24.69% | 39 053 M $ | |
-10.53% | 38 812 M $ | |
+37.03% | 38 287 M $ |
- Stock
- Equities
- Stock Vistra Corp. - Nyse
- Financials Vistra Corp.